Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.

Jack H. Simon, David K.b. Li, Anthony Traboulsee, Patricia K. Coyle, Douglas L. Arnold, Frederik Barkhof, J A Frank, Robert L. Grossman, D. W. Paty, Ernst‐Wilhelm Radue, Jerry S. WolinskyPubMed 2006

TL;DR

This paper presents consensus guidelines for a standardized MR imaging protocol for diagnosing and monitoring Multiple Sclerosis (MS). The goal is to improve consistency and comparability of imaging data across different centers and studies, ultimately leading to more accurate diagnoses and better treatment evaluations.

What Problem Does This Paper Address?

Multiple Sclerosis (MS) is a complex neurological disease affecting the brain and spinal cord. Magnetic Resonance Imaging (MRI) has become an indispensable tool for understanding MS, detecting lesions, and monitoring disease progression. However, a lack of standardized MRI protocols across different clinical settings and research studies has led to variability in image acquisition and interpretation. This inconsistency hinders accurate diagnosis, makes it difficult to compare results from clinical trials, and complicates the assessment of treatment effectiveness. The paper addresses this by proposing a consensus-driven, standardized MR imaging protocol to ensure uniformity and improve the reliability of MS imaging.

Methods

The paper outlines a standardized MR imaging protocol for both brain and spinal cord, developed through a consensus process involving neurologists and radiologists. The protocol specifies recommended sequences, their diagnostic purpose (e.g., for clinically isolated syndrome, baseline, or follow-up scans), and specific parameters like section thickness and contrast administration. It also details criteria for dissemination in space and time, based on international panel guidelines, and provides recommendations for initial evaluation, follow-up imaging, and reporting. The methodology involved expert meetings, platform presentations, and regional discussions to refine the guidelines.

Datasets

Not discussed in the paper. The paper focuses on establishing a standardized protocol rather than evaluating it on specific datasets.

Key Insights and Ideas

  • Standardization is Crucial for MS Diagnosis and Research: The core idea is that consistent MR imaging protocols are essential for reliable MS diagnosis, tracking disease progression, and evaluating treatment efficacy across different institutions and studies.
  • Bridging the Gap Between Clinical Trials and Practice: The guidelines aim to translate findings from controlled clinical trials to routine clinical practice, ensuring that the imaging used in individual patient care aligns with the rigorous standards of research.
  • MRI as a Key Diagnostic Tool: The paper emphasizes the growing role of MRI in establishing an MS diagnosis, even accelerating it by months or years, by providing evidence of disease dissemination in time and space.
  • Beyond Lesion Counting: While lesion counts are important, the guidelines also touch upon the significance of assessing normal-appearing white and gray matter, and the potential future role of quantitative measures.
  • Balancing Standardization with Flexibility: The consensus process acknowledges that while standardization is key, there's a need for some flexibility to accommodate individual patient needs (e.g., claustrophobia) and evolving imaging technologies.

Key Results

The paper presents detailed tables outlining recommended MR imaging protocols for brain and spinal cord, including specific sequences like FLAIR, PD/T2-weighted, and T1-weighted scans. It also provides criteria for dissemination in space and time, which are crucial for diagnosing MS. The consensus guidelines offer a structured approach for initial evaluation, follow-up, and reporting, aiming to minimize errors in interpretation and improve the comparability of imaging data.

Limitations and Future Work

  • Pediatric MS: The recommendations may not be directly applicable to pediatric MS, and further studies are needed to address optimal imaging standardization in this population.
  • Primary Progressive MS: The current criteria, based on focal lesions, may become less helpful in the secondary progressive stage of MS, and there are no specific alternative imaging recommendations for primary progressive MS at this time.
  • Quantitative Measures: While advanced quantitative imaging techniques (e.g., MT imaging, diffusion imaging, MR spectroscopy) are recognized for their potential, they are not yet considered practical for routine clinical evaluation due to validation and standardization issues.
  • Evolving Technology: The authors acknowledge that these guidelines will likely require modification as imaging technology, pulse sequences, and quantitative methodologies evolve.
  • Routine Follow-up Scans: Routine follow-up MR imaging scans are generally not recommended in the absence of clinical indications, though some experts expressed minority dissenting opinions. The authors suggest that with increased experience and standardization, future recommendations might include routine follow-up imaging.

Summary updated

Abstract

MR imaging has played an important role in contributing to our understanding of the natural history of multiple sclerosis (MS) in the brain and spinal cord, including its expression as both a focal (plaque) and more diffuse disease affecting normal-appearing white and gray matter, the latter
BibTeX
@inproceedings{simon2006standardized,
  author = {Jack H. Simon and David K.B. Li and Anthony Traboulsee and Patricia K. Coyle and Douglas L. Arnold and Frederik Barkhof and J A Frank and Robert L. Grossman and D. W. Paty and Ernst‐Wilhelm Radue and Jerry S. Wolinsky},
  title = {{Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.}},
  booktitle = {PubMed},
  year = {2006},
}
Figure